In mechanism, MG53, as an E3 ligase, performs ubiquitin-dependent degradation of insulin receptor (IR) and insulin receptor substrate (IRS1), leading to insulin resistance and metabolic disorders. This evidence concerns the gene INSR and Other metabolic disease.